Pulmonary Function Testing Devices Market By Product, By Test Type, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031

Description

List of Tables

Pulmonary function testing is a series of tests that can determine as well as measure the efficacy of inhaling and exhaling functions performed by the lungs. It plays a pivotal role in determining the efficient transfer of oxygen into the blood and helps in diagnosing certain types of lung diseases such as asthma, bronchitis, and emphysema, along with determining the cause of shortness of breath.

Some of the common types of pulmonary function tests are spirometry. Spirometry measures how much air a person can breathe in and out. It also measures how fast a person can empty the air out of the lungs. This test is done to check how well the oxygen moves from the lungs into the bloodstream.

The key factors that drive the growth of the market are the rise in the prevalence of lung cancer and lung-related disorders; rise in the geriatric population; and the increase in adoption of technologically advanced medical devices across the world. In addition, rise in the demand for minimally invasive tests for lung diseases across the key is the key factor which further boosts the market growth. For instance, according to the World Health Organization, in 2020, chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide. It was estimated that around 3.9 million people died due to COPD. Furthermore, increase in the geriatric population and the rise in the prevalence of chronic lung diseases has increased the demand pulmonary function testing devices for disease diagnosis across the world which further boost the market growth.

Moreover, increase in R&D activity for pulmonary function testing devices, and a rise in healthcare expenditures further boost the growth of market. However, the high cost of medical devices and a lack of awareness of pulmonary tests hamper the market growth. Conversely, the emerging healthcare market in developing countries is expected to provide a lucrative opportunity for the key players operating in the market during the forecast period.

The pulmonary function testing devices market is segmented on the basis of product, test type, application, end user, and region. On the basis of product, it is segmented into portable PFT devices and complete PFT systems. On the basis of test type, the market is segmented into spirometry, peak flow meter, lung volume test, gas exchange testing, maximal voluntary ventilation, and others. On the basis of application, it is segmented into chronic obstructive pulmonary disorders, asthma, chronic shortness of breath, restrictive lung disease and others. On the basis of end user, the market is segmented into hospitals, diagnostic centers, clinical laboratories and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America dominated pulmonary function testing devices in 2021 and is anticipated to remain dominant during the forecast period due to rise in healthcare expenditure and the presence of major players in the in this region.

Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rise in prevalence of chronic diseases and increase in geriatric population.

The key players that operate in the pulmonary function testing devices market are Chest M.I Inc, Clarity Medical Pvt. Ltd., Cosmed srl, Data Sciences International Inc, Eco Medics AG, Geratherm Medical AG, JK Medical System Pvt. Ltd., Medical Electronic Construction, Medical Equipment Europe GmbH, MGC Diagnostics Corporation, Morgan Scientific Inc, NDD Medical Technologies Inc, Omron Corporation, Pulm One Advanced Medical Devices Ltd., Schiller AG, Koko LLC, and Vyaire Medical Inc

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pulmonary function testing devices market analysis from 2021 to 2031 to identify the prevailing pulmonary function testing devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the pulmonary function testing devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global pulmonary function testing devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Portable PFT Devices
- Type
- Hardware
- Software
Complete PFT Devices
- Type
- Hardware
- Software

By Test Type

Spirometry
Peak flow meter
Lung Volume Test
Gas Exchange Testing
Maximal Voluntary Ventilation
Others

By Application

Chronic Obstructive Pulmonary Disease
Asthma
Chronic Shortness of Breath
Restrictive Lung Disease
Others

By End user

Hospital
Clinical laboratories
Diagnostic Laboratories
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest Of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest Of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- SCHILLER
- COSMED srl
- NSPIRE HEALTH INC
- MGC Diagnostics Corporation
- ndd Medizintechnik AG
- Morgan Scientific Inc.,
- Ganshorn Medizin Electronic
- Minato Holdings Inc
- CHEST M.I., Inc
- Medical Equipment Europe

Product Code: A03407

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Portable PFT Devices
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Portable PFT Devices Pulmonary Function Testing Devices Market by Type
  - 4.2.4.1 Hardware Market size and forecast, by region
  - 4.2.4.2 Software Market size and forecast, by region
4.3 Complete PFT Devices
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Complete PFT Devices Pulmonary Function Testing Devices Market by Type
  - 4.3.4.1 Hardware Market size and forecast, by region
  - 4.3.4.2 Software Market size and forecast, by region

CHAPTER 5: PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Spirometry
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Peak flow meter
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Lung Volume Test
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Gas Exchange Testing
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Maximal Voluntary Ventilation
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
5.7 Others
- 5.7.1 Key market trends, growth factors and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market analysis by country

CHAPTER 6: PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Chronic Obstructive Pulmonary Disease
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Asthma
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Chronic Shortness of Breath
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
6.5 Restrictive Lung Disease
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
6.6 Others
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country

CHAPTER 7: PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER

7.1 Overview
- 7.1.1 Market size and forecast
7.2 Hospital
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
7.3 Clinical laboratories
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
7.4 Diagnostic Laboratories
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
7.5 Others
- 7.5.1 Key market trends, growth factors and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market analysis by country

CHAPTER 8: PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION

8.1 Overview
- 8.1.1 Market size and forecast
8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Product
  - 8.2.2.1 North America Portable PFT Devices Pulmonary Function Testing Devices Market by Type
  - 8.2.2.2 North America Complete PFT Devices Pulmonary Function Testing Devices Market by Type
- 8.2.3 North America Market size and forecast, by Test Type
- 8.2.4 North America Market size and forecast, by Application
- 8.2.5 North America Market size and forecast, by End user
- 8.2.6 North America Market size and forecast, by country
  - 8.2.6.1 U.S.
  - 8.2.6.1.1 Market size and forecast, by Product
  - 8.2.6.1.2 Market size and forecast, by Test Type
  - 8.2.6.1.3 Market size and forecast, by Application
  - 8.2.6.1.4 Market size and forecast, by End user
  - 8.2.6.2 Canada
  - 8.2.6.2.1 Market size and forecast, by Product
  - 8.2.6.2.2 Market size and forecast, by Test Type
  - 8.2.6.2.3 Market size and forecast, by Application
  - 8.2.6.2.4 Market size and forecast, by End user
  - 8.2.6.3 Mexico
  - 8.2.6.3.1 Market size and forecast, by Product
  - 8.2.6.3.2 Market size and forecast, by Test Type
  - 8.2.6.3.3 Market size and forecast, by Application
  - 8.2.6.3.4 Market size and forecast, by End user
8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Product
  - 8.3.2.1 Europe Portable PFT Devices Pulmonary Function Testing Devices Market by Type
  - 8.3.2.2 Europe Complete PFT Devices Pulmonary Function Testing Devices Market by Type
- 8.3.3 Europe Market size and forecast, by Test Type
- 8.3.4 Europe Market size and forecast, by Application
- 8.3.5 Europe Market size and forecast, by End user
- 8.3.6 Europe Market size and forecast, by country
  - 8.3.6.1 France
  - 8.3.6.1.1 Market size and forecast, by Product
  - 8.3.6.1.2 Market size and forecast, by Test Type
  - 8.3.6.1.3 Market size and forecast, by Application
  - 8.3.6.1.4 Market size and forecast, by End user
  - 8.3.6.2 Germany
  - 8.3.6.2.1 Market size and forecast, by Product
  - 8.3.6.2.2 Market size and forecast, by Test Type
  - 8.3.6.2.3 Market size and forecast, by Application
  - 8.3.6.2.4 Market size and forecast, by End user
  - 8.3.6.3 Italy
  - 8.3.6.3.1 Market size and forecast, by Product
  - 8.3.6.3.2 Market size and forecast, by Test Type
  - 8.3.6.3.3 Market size and forecast, by Application
  - 8.3.6.3.4 Market size and forecast, by End user
  - 8.3.6.4 UK
  - 8.3.6.4.1 Market size and forecast, by Product
  - 8.3.6.4.2 Market size and forecast, by Test Type
  - 8.3.6.4.3 Market size and forecast, by Application
  - 8.3.6.4.4 Market size and forecast, by End user
  - 8.3.6.5 Spain
  - 8.3.6.5.1 Market size and forecast, by Product
  - 8.3.6.5.2 Market size and forecast, by Test Type
  - 8.3.6.5.3 Market size and forecast, by Application
  - 8.3.6.5.4 Market size and forecast, by End user
  - 8.3.6.6 Rest of Europe
  - 8.3.6.6.1 Market size and forecast, by Product
  - 8.3.6.6.2 Market size and forecast, by Test Type
  - 8.3.6.6.3 Market size and forecast, by Application
  - 8.3.6.6.4 Market size and forecast, by End user
8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Product
  - 8.4.2.1 Asia-Pacific Portable PFT Devices Pulmonary Function Testing Devices Market by Type
  - 8.4.2.2 Asia-Pacific Complete PFT Devices Pulmonary Function Testing Devices Market by Type
- 8.4.3 Asia-Pacific Market size and forecast, by Test Type
- 8.4.4 Asia-Pacific Market size and forecast, by Application
- 8.4.5 Asia-Pacific Market size and forecast, by End user
- 8.4.6 Asia-Pacific Market size and forecast, by country
  - 8.4.6.1 Japan
  - 8.4.6.1.1 Market size and forecast, by Product
  - 8.4.6.1.2 Market size and forecast, by Test Type
  - 8.4.6.1.3 Market size and forecast, by Application
  - 8.4.6.1.4 Market size and forecast, by End user
  - 8.4.6.2 China
  - 8.4.6.2.1 Market size and forecast, by Product
  - 8.4.6.2.2 Market size and forecast, by Test Type
  - 8.4.6.2.3 Market size and forecast, by Application
  - 8.4.6.2.4 Market size and forecast, by End user
  - 8.4.6.3 India
  - 8.4.6.3.1 Market size and forecast, by Product
  - 8.4.6.3.2 Market size and forecast, by Test Type
  - 8.4.6.3.3 Market size and forecast, by Application
  - 8.4.6.3.4 Market size and forecast, by End user
  - 8.4.6.4 Australia
  - 8.4.6.4.1 Market size and forecast, by Product
  - 8.4.6.4.2 Market size and forecast, by Test Type
  - 8.4.6.4.3 Market size and forecast, by Application
  - 8.4.6.4.4 Market size and forecast, by End user
  - 8.4.6.5 South Korea
  - 8.4.6.5.1 Market size and forecast, by Product
  - 8.4.6.5.2 Market size and forecast, by Test Type
  - 8.4.6.5.3 Market size and forecast, by Application
  - 8.4.6.5.4 Market size and forecast, by End user
  - 8.4.6.6 Rest of Asia-Pacific
  - 8.4.6.6.1 Market size and forecast, by Product
  - 8.4.6.6.2 Market size and forecast, by Test Type
  - 8.4.6.6.3 Market size and forecast, by Application
  - 8.4.6.6.4 Market size and forecast, by End user
8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Product
  - 8.5.2.1 LAMEA Portable PFT Devices Pulmonary Function Testing Devices Market by Type
  - 8.5.2.2 LAMEA Complete PFT Devices Pulmonary Function Testing Devices Market by Type
- 8.5.3 LAMEA Market size and forecast, by Test Type
- 8.5.4 LAMEA Market size and forecast, by Application
- 8.5.5 LAMEA Market size and forecast, by End user
- 8.5.6 LAMEA Market size and forecast, by country
  - 8.5.6.1 Brazil
  - 8.5.6.1.1 Market size and forecast, by Product
  - 8.5.6.1.2 Market size and forecast, by Test Type
  - 8.5.6.1.3 Market size and forecast, by Application
  - 8.5.6.1.4 Market size and forecast, by End user
  - 8.5.6.2 Saudi Arabia
  - 8.5.6.2.1 Market size and forecast, by Product
  - 8.5.6.2.2 Market size and forecast, by Test Type
  - 8.5.6.2.3 Market size and forecast, by Application
  - 8.5.6.2.4 Market size and forecast, by End user
  - 8.5.6.3 South Africa
  - 8.5.6.3.1 Market size and forecast, by Product
  - 8.5.6.3.2 Market size and forecast, by Test Type
  - 8.5.6.3.3 Market size and forecast, by Application
  - 8.5.6.3.4 Market size and forecast, by End user
  - 8.5.6.4 Rest of LAMEA
  - 8.5.6.4.1 Market size and forecast, by Product
  - 8.5.6.4.2 Market size and forecast, by Test Type
  - 8.5.6.4.3 Market size and forecast, by Application
  - 8.5.6.4.4 Market size and forecast, by End user

CHAPTER 9: COMPANY LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES

10.1 SCHILLER
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
10.2 COSMED srl
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
10.3 NSPIRE HEALTH INC
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
10.4 MGC Diagnostics Corporation
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
10.5 ndd Medizintechnik AG
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
10.6 Morgan Scientific Inc.,
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
10.7 Ganshorn Medizin Electronic
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
10.8 Minato Holdings Inc
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
10.9 CHEST M.I., Inc
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
10.10 Medical Equipment Europe
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments